Beyond the
"Intractable disease treatment"

To compare the future with every intractable disease treatment by power of chemistry，Chemiteras works on realization of "non-illness" of there day and night.

About us

Characteristic of Chemiteras


We self-develope the therapeutic drug

We develop a therapeutic drug in-house ,
And do until animal experiment
Development of the compound semiconductor-manufacturing equipment Technologies
We develop new material to make use of Technique of the compound semiconductor-manufacturing equipment
Management and utilization of Intellectual Property 
We Management of Intellectual Property of own company and joint development,
We perform medicine manufacture, manufacture utilizing an Intellectual Property
Management and utilization of Intellectual Property 
We Management of Intellectual Property of own company and joint development,
We perform medicine manufacture, manufacture utilizing an Intellectual Property

Beyond The "Intractable disease treatment"

We Proffer every effort and service
To treat "an intractable disease" in the world
and
To realize "non-illness"

Service

Pharmaceutical
R＆D
We perform the joint development with a researcher and the university for the research and development of pharmaceutical products as well as the company and deal with a study, an experiment, the development of the therapeutic drug.
Equipment
Manufacturing
By the technique of the compound semiconductor device,
I develop advanced material and the new material as well as medicine, medical supplies.
Intellectual property
Management
I am strong in the acquisition and the inflection of a drug patent and production, the device patent and give the Intellectual Property Management Div. law of nature free in the common enterprise with other companies as well as the company.
Intellectual property
Management
I am strong in the acquisition and the inflection of a drug patent and production, the device patent and give the Intellectual Property Management Div. law of nature free in the common enterprise with other companies as well as the company.


Company's Profile

Chemiteras,Inc.
Company name Chemiteras,Inc.
Head Office 3-chome-24-5 Shinnyokohama,Kohoku Ward, Yokohama, Kanagawa, 222-0033, Japan
company representative Tokinori Terada
foundation 2017.9.13
Business Investigation, Acquisition, Selling of in-house development medicina and product
E-mail address info@chemiteras.com
E-mail address info@chemiteras.com

News Release





Nov.2020		 Our SDG's project "UNIFY" in Switzerland was featured in the G20 report.
UNIFY is a platform that supports researchers and their work around the world and connects people, companies, and research, and is attracting attention for accelerating the SDG's by utilizing UNIFY.

■G20 Report (UNIFY is on pages 156 and 157)
This report is subscribed to by heads of state, government executives, Forbes 500 executives, and first class passengers.

Aug.2019		 Signed an advisory agreement with Dr. Torkel Falkenberg, Representative at the Board of the Swedish Karolinska Institute (the world's best medical research institution).
Mar.2019 Joint development medicina：
Patent applications of Cancer therapeutic drug of the brain
Feb.2019 In-house development medicina：
Patent application of the mitochondrial related medicine
Aug.2018 In-house development medicina：
Patent applications of Hyperuricemia therapeutic drug
Mar.2019 Joint development medicina：
Patent applications of Cancer therapeutic drug of the brain

Map

Contact Us

Please contact the following button for inquiries and media requests to our company.

Contact Us